Nefopam-Zdorovye solution for injection 20 mg/2 ml ampoule 2 ml in blister No. 5
Nefopam-Health injection solution is used for the following indications:
postoperative analgesia as part of multimodal analgesia (nefopam also exhibits a positive property of preventing postoperative tremor); symptomatic treatment of acute pain conditions (injuries, pain after surgical operations, analgesia of renal and hepatic colic).Composition
The active substance is nefopam hydrochloride (one ampoule (2 ml) of the drug contains 20 mg of nefopam hydrochloride).
Excipients: sodium hydrogen phosphate, sodium dihydrogen phosphate anhydrous, water for injections.
Contraindication
hypersensitivity to nefopam or other components of the drug; children's age up to 15 years, due to the lack of clinical studies; seizures or their presence in history; risk of urinary retention associated with urethroprostatic disorders; risk of acute glaucomatous attack; simultaneous use of MAO inhibitors.Method of application
Therapy should correspond to the intensity of the pain syndrome and the patient's response.
Intramuscular injection
The drug should be administered intramuscularly deep. A dose of 20 mg is recommended for one injection. If necessary, the injection should be repeated every 6 hours. The maximum daily dose is 120 mg.
Intravenous administration
The drug should be administered as a continuous infusion over at least 15 minutes, the patient should be in a supine position to avoid some adverse reactions, such as nausea, dizziness, sweating. The dose per injection is 20 mg. If necessary, repeat the injection every 4 hours.
The maximum daily dose is 120 mg.
Introduction method
The drug can be administered in a standard infusion solution (0.9% sodium chloride solution or 5% glucose solution). The optimal dilution ratio is one ampoule of the drug in 50 ml of infusion solution.
The course of treatment is no more than 8-10 days.
Application features
Pregnant women
For safety reasons, the drug should not be used during pregnancy.
The drug passes into breast milk to such an extent that exposure to breastfed newborns/infants is likely. Should not be used during breastfeeding.
Children
Do not use in children under 15 years of age.
Drivers
The possible risk of drowsiness during treatment should be taken into account, which may affect the ability to drive or operate other mechanisms.
Overdose
Symptoms of anticholinergic origin: tachycardia, coma, convulsions, hallucinations.
Treatment: symptomatic treatment with cardiological and respiratory monitoring in a hospital setting.
Side effects
From the nervous system: very often (≥ 1/10) - drowsiness; often (≥ 1/100, <1/10) - dizziness.
Cardiac disorders: often (≥ 1/100, <1/10) - tachycardia, palpitations.
Gastrointestinal tract: very often (≥ 1/10) - nausea, vomiting; often (≥ 1/100, <1/10) - dry mouth.
Renal and urinary disorders: common (≥ 1/100, <1/10) - urinary retention.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C, out of the reach of children.
Shelf life - 2 years.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.